Literature DB >> 24338347

Yield optimisation and molecular characterisation of uncultured CD271+ mesenchymal stem cells in the Reamer Irrigator Aspirator waste bag.

Sarah M Churchman1, Dimitrios Kouroupis, Sally A Boxall, Tarek Roshdy, Hiang B Tan, Dennis McGonagle, Peter V Giannoudis, Elena A Jones.   

Abstract

Bone reconstruction requires the use of autografts from patients' iliac crest (IC); for large-volume defects bone void fillers and autologous mesenchymal stem cells (MSCs) are often added. The Reamer/Irrigator/Aspirator (RIA) device provides the means of harvesting large amounts of autograft and additionally yields a waste bag containing MSCs, which is currently discarded. The aim of this study was to enumerate and characterise native MSCs from RIA waste bag and compare them to 'gold-standard' donor-matched MSCs from IC bone marrow (BM). IC-BM from age matched trauma patients was used as control. In RIA waste bags the median MSC yield established using a colony-forming fibroblast assay was 314333 (range 5 x 104-1.4 x 106), equivalent to approximately one litre of IC-BM aspirate. CD271+ cells were present at high levels in RIA waste bags, had MSC surface phenotype (CD90+CD73+CD105+CD34>sup>-CD61-CD19-CD31-CD33-) and expressed genes associated with multipotentiality, osteogenesis, adipogenesis and angiogenic support. RIA- CD271+ MSCs were transcriptionally similar to donor-matched IC-CD271+ MSCs (76 % transcripts); with the majority of bone-related and Wnt pathway molecules being expressed at comparable levels. Lower-level expression of MCAM/CD146 and 5/13 hypoxia-related molecules was found in RIA-CD271+ MSCs, potentially reflecting their native residence in a more hypoxic environment of the endosteum and bone cortex. These data suggest that long bones contain very large numbers of MSCs, transcriptionally-similar to IC-BM MSCs; they can be procured by reaming using the RIA device and used, following concentration, as autologous and potentially allogeneic bone repair therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24338347     DOI: 10.22203/ecm.v026a18

Source DB:  PubMed          Journal:  Eur Cell Mater        ISSN: 1473-2262            Impact factor:   3.942


  9 in total

1.  SOST, an LNGFR target, inhibits the osteogenic differentiation of rat ectomesenchymal stem cells.

Authors:  Gang Li; Junyu Liu; Manzhu Zhao; Yingying Wang; Kun Yang; Chang Liu; Yong Xiao; Xiujie Wen; Luchuan Liu
Journal:  Cell Prolif       Date:  2017-12-10       Impact factor: 6.831

2.  The osteogenic commitment of CD271+CD56+ bone marrow stromal cells (BMSCs) in osteoarthritic femoral head bone.

Authors:  Dragos C Ilas; Thomas G Baboolal; Sarah M Churchman; William G Jones; Peter V Giannoudis; Hans-Jörg Bühring; Dennis McGonagle; Elena Jones
Journal:  Sci Rep       Date:  2020-07-07       Impact factor: 4.379

3.  Bone Marrow-Harvesting Technique Influences Functional Heterogeneity of Mesenchymal Stem/Stromal Cells and Cartilage Regeneration.

Authors:  Kavitha Sivasubramaniyan; Dragos C Ilas; Abhishek Harichandan; Pieter K Bos; Diego L Santos; Peter de Zwart; Wendy J L M Koevoet; Heather Owston; Hans-Jörg Bühring; Elena Jones; Gerjo J V M van Osch
Journal:  Am J Sports Med       Date:  2018-11-12       Impact factor: 6.202

4.  Colony Formation, Migratory, and Differentiation Characteristics of Multipotential Stromal Cells (MSCs) from "Clinically Accessible" Human Periosteum Compared to Donor-Matched Bone Marrow MSCs.

Authors:  Heather E Owston; Payal Ganguly; Giuseppe Tronci; Stephen J Russell; Peter V Giannoudis; Elena A Jones
Journal:  Stem Cells Int       Date:  2019-11-21       Impact factor: 5.443

5.  Examining the feasibility of clinical grade CD271+ enrichment of mesenchymal stromal cells for bone regeneration.

Authors:  Richard J Cuthbert; Peter V Giannoudis; Xiao N Wang; Lindsay Nicholson; David Pawson; Anatole Lubenko; Hiang B Tan; Anne Dickinson; Dennis McGonagle; Elena Jones
Journal:  PLoS One       Date:  2015-03-11       Impact factor: 3.240

Review 6.  Where is the common ground between bone marrow mesenchymal stem/stromal cells from different donors and species?

Authors:  Elena Jones; Richard Schäfer
Journal:  Stem Cell Res Ther       Date:  2015-08-18       Impact factor: 6.832

7.  Bone marrow-derived mesenchymal stem cells migrate to healthy and damaged salivary glands following stem cell infusion.

Authors:  Silke Schwarz; Ralf Huss; Michaela Schulz-Siegmund; Breda Vogel; Sven Brandau; Stephan Lang; Nicole Rotter
Journal:  Int J Oral Sci       Date:  2014-05-09       Impact factor: 6.344

8.  Intralesional Injection of Bone Marrow Aspirate Concentrate for the Treatment of Osteonecrosis of the Knee Secondary to Systemic Lupus Erythematosus: A Case Report.

Authors:  Dimitrios Kouroupis; Amir F Ahari; Diego Correa; Riam Shammaa
Journal:  Front Bioeng Biotechnol       Date:  2020-03-20

9.  Comparing the efficacy of syngeneic iliac and femoral allografts with iliac crest autograft in a rat model of lumbar spinal fusion.

Authors:  Christina Holmes; Benjamin D Elder; Wataru Ishida; Alexander Perdomo-Pantoja; John Locke; Ethan Cottrill; Sheng-Fu L Lo; Timothy F Witham
Journal:  J Orthop Surg Res       Date:  2020-09-15       Impact factor: 2.359

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.